EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes

Sherry Ershadi, John S Barbieri

Cutis · 2025

DOI: 10.12788/cutis.1239 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cutis, 2025. Verfasst von Sherry Ershadi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Spironolactone, Acne Vulgaris, Mineralocorticoid Receptor Antagonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spironolactone is an effective systemic treatment for acne in women and likely is an underutilized alternative to oral antibiotics. It is used off label for all types of acne and has shown effectiveness for both facial and truncal acne. We recommend a starting dose of 100 mg/d, as most patients can tolerate it and it has superior effectiveness to lower doses. The most common adverse effects of spironolactone are lightheadedness; headache; and menstrual irregularities, which tend to be dose dependent and can be prevented or treated using combined oral contraceptives. Potassium monitoring is of low usefulness in young healthy women, and studies have not identified an association between spironolactone use and increased risk for cancer. This article provides an overview of spironolactone for the treatment of acne, including recent clinical trials and practical strategies for patient selection, dosing, adverse effect management, and monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpironolactoneAcne VulgarisMineralocorticoid Receptor AntagonistsHumansFemaleDose-Response Relationship, DrugTreatment OutcomePatient Selection

Substanzen

SpironolactoneMineralocorticoid Receptor Antagonists

Autor:innen und Institutionen

  • Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

Zitieren

APA

Ershadi, S., & Barbieri, J. S. (2025). Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes. Cutis. https://doi.org/10.12788/cutis.1239

Vancouver

Ershadi S, Barbieri JS. Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes. Cutis. 2025. doi:10.12788/cutis.1239

BibTeX
@article{Ershadi2025,
  author = {Ershadi, Sherry and Barbieri, John S},
  title = {Spironolactone for Acne: Practical Strategies for Optimal Clinical Outcomes},
  journal = {Cutis},
  year = {2025},
  doi = {10.12788/cutis.1239}
}
Kostenlos starten →